Allograft aortic valve replacement in the adult: A review

Heart Lung and Circulation

Volumn 13, Issue 1, 2004, Pages 41-51

  Yap, Cheng Hon ^a   Yii, Michael ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b GEELONG HOSPITAL   (Australia)

Author keywords

Allograft; Aortic valve replcement; Endocarditis; Heart valve disease

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROPIOLACTONE; STEROID;

ALLOGRAFT; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CRYOPRESERVATION; ENDOCARDITIS; FOLLOW UP; FREEZE DRYING; HEART TRANSPLANTATION; HEMODYNAMICS; HISTORY OF MEDICINE; HUMAN; IMMUNOLOGY; IRRADIATION; LONG TERM CARE; OUTCOMES RESEARCH; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOGENICITY;

EID: 21344473933     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2004.01.012     Document Type: Review

References (87)

1. Lund O, Chandrasekaran V, Grocott-Mason R, Elwidaa H, Mazhar R, Khaghani A, et al. Primary aortic valve replacement with allografts over twenty-five years: valve related and procedure related determinants of outcome. J Thorac Cardiovasc Surg 1999;17:77-91.
2. O'Brien MF, Harrocks S, Stafford EG, Gardner MAH, Pohlner PG, Tesar PJ, et al. The homograft aortic valve: a 29-year, 99.3% follow up of 1022 valve replacements. J Heart Valve Dis 2001; 10:334-45.
3. Ross D. Replacement of the aortic valve. Lancet 1962; 42:487.
4. Barratt-Boyes BG. Homograft aortic valve replacement in aortic incompetence and stenosis. Thorax 1964;19:131-50.
5. Murray G. Homologous aortic-valve segment transplants as surgical treatment for aortic and mitral insufficiency. Angiology 1956;7:46.
6. Kerwin AJ, Lenkei SC, Wilson DR. Aortic-valve homograft in the treatment of aortic insufficiency: report of nine cases, with one followed for six years. N Engl J Med 1962;266:852.
7. Daly RC, Orszulak TA, Schaff HV, McGovern E, Wallace RB. Long-term results of aortic valve replacement with nonviable homografts. Circulation 1991;84(Suppl 5):III81-8.
8. Bodnar E, Matsuki O, Parker R, Ross DN. Viable and nonviable aortic homografts in the subcoronary position: a comparative study. Ann Thorac Surg 1989;47:799-805.
9. Paneth M, O'Brien MF. Transplantation of human homograft aortic valve. Thorax 1966;21:115-7.
10. Barratt-Boyes BG. Long-term follow-up of aortic valvar grafts. Br Heart J 1971;33(Suppl):60-5.
11. Angel WW, Iben AB, Shumway NE. Fresh aortic homografts for multiple valve replacements. Arch Surg 1968;97:826-30.
12. Barratt-Boyes BG, Roche AHG, Whitlock RML. Six year review of the results of freehand aortic valve replacement using an antibiotic sterilized homograft valve. Circulation 1977;55:353-61.
13. Yacoub M, Kittle CF. Sterilisation of valve homografts by antibiotic solutions. Circulation 1970;41(5 Suppl):II29-32.
14. Angell WW, Angell JD, Oury JD, Oury JH, Lambert JJ, Grehl TM. Long-term follow-up of viable frozen aortic homografts: a viable homograft valve bank. J Thorac Cardiovasc Surg 1987; 93:815-22.
15. O'Brien MF, Stafford G, Gardner MAH, Pohlner P, McGiffin D, Johnston N, et al. The viable cryopreserved allograft aortic valve. J Card Surg 1987;1(Suppl):153.
16. O'Brien MF, Stafford EG, Gardner MAH, Pohlner P, McGiffin D, Kirklin JW. A comparison of aortic valve replacement with viable cryopreserved and fresh aortic valve replacement with a note on chromosomal studies. J Thorac Cardiovasc Surg 1987; 94:812-23.
17. Khaghani A, Dhalla N, Penta S, Qureshi S, Theodoropoulos S, Esposito G, et al. Patient status 10 years or more after aortic valve replacement using antibiotic sterilized homografts. In: Bodnar E, Yacoub MH, editors. Biologic and bioprosthetic valves. Proceedings of the Third International Symposium. New York: Yorke Medical Books; 1986. p. 38-46.
18. Virdi IS, Monro JL, Ross JK. Eleven year experience of aortic valve replacement with antibiotic sterilized homograft valves in Southampton. Thorac Cardiovasc Surg 1986;34:277-82.
19. Matsuki O, Robles A, Gibbs S, Bodnar E, Ross D. Long-term performance of 555 aortic homografts in the aortic position. Ann Thorac Surg 1988;46:187-91.
20. Jaffe WM, Coverdale HA, Roche AH, Whitlock RM, Neutze JM, Barratt-Boyes BG. Rest and exercise hemodynamics of 20-23 mm allograft, medtronic intact (porcine), and St. Jude Medical valves in the aortic position. J Thorac Cardiovasc Surg 1990;100:167-74.
21. Albertucci M. Aortic Valvular allografts and pulmonary autografts. In: Edmunds LH, editor. Cardiac surgery in the adult, 1st ed. McGraw-Hill Professional; 1997.
22. Jin XY, Zhang ZM, Gibson DG, Yacoub MH, Pepper JR. Effects of valve substitute on changes in left ventricular function and hyperthrophy after aortic valve replacement. Ann Thorac Surg 1996; 62:683-90.
23. Barratt-Boyes BG, Roche AH, Subramanyam R, Pemberton JR, Whitlock RML. Long-term follow-up of patients with the antibiotic-sterilised aortic homograft valve inserted freehand in the aortic position. Circulation 1987;75:768-77.
24. Ivert TSA, Dismukes WE, Cobbs GC, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation 1984; 69:223.
25. McGiffin DC, Kirklin JK. The impact of aortic valve homografts on the treatment of aortic prosthetic valve endocarditis. Semin Thorac Cardiovasc Surg 1995;7:25-31.
26. Haydock D, Barratt-Boyes B, Macedo T, Kirklin JW, Blackstone E. Aortic valve replacement for active infectious endocarditis in 108 patients: a comparison of freehand allograft valves with mechanical prostheses and bioprostheses. J Thorac Cardiovasc Surg 1992; 103(1):130-9.
27. McGiffin DC, Galbraith AJ, McLachlan GJ, Stower RE, Wong ML, Stafford EG, et al. Aortic valve infection: risk factors for death and recurrent endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 1992;104:511-20.
28. Petrou M, Wong K, Albertucci M, Brecker SJ, Yacoub MH. Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis. Circulation 1994;90(5 Pt 2):II198-204.
29. Niwaya K, Knott-Craig CJ, Santangelo K, Lane MM, Chandrasekaran K, Elkins RC. Advantage of autograft and homograft valve replacement for complex aortic valve endocarditis. Ann Thorac Surg 1999;67(6):1603-8.
30. Sabik JF, Lytle BW, Blackstone EH, Marullo AG, Pettersson GB, Cosgrove DM. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 2002; 74(3):650-9.
31. Edmunds LH, Clark RE, Cohn LH, Craig Miller D, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1988;46:257-9.
32. Yacoub M, Rasmi NR, Sundt TM, Lund O, Boyland E, Radley-Smith R, et al. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995; 110:186-94.
33. O'Brien MF, Johnston N, Stafford G, Gardner M, Pohlner P, McGiffin D, et al. A study of the cells in the explanted viable cryopreserved allograft valve. J Card Surg 1988;3(3 Suppl):279-87.
34. Koolbergen DR, Hazekamp MG, de Heer E, Bruggemans EF, Huysmans HA, Dion RA, et al. The pathology of fresh and cryopreserved homograft heart valves: an analysis of forty explanted homograft valves. J Thorac Cardiovasc Surg 2002;124:689-97.
35. Mitchell RN, Jonas RA, Schoen FJ. Pathology of explanted cryopreserved allograft heart valves: comparison with aortic valves from orthotopic heart transplants. J Thorac Cardiovasc Surg 1998; 115:118-27.
36. Mitchell RN, Jonas RA, Schoen FJ. Structure-function correlations in cryopreserved allograft cardiac valves. Ann Thorac Surg 1995;60:S108-13.
37. Koolbergen DR, Hazekamp MG, Kurvers M, de Heer E, Cornelisse CJ, Huysmans HA, et al. Tissue chimerism in human cryopreserved homograft valve explants demonstrated by in situ hybridisation. Ann Thorac Surg 1998;66(6 Suppl):S225-32.
38. Gonzalez-Lavin L, Spotnitz AJ, Mackenzie JW, Gu J, Gadi IK, Gullo J, et al. Homograft valve durability: host or donor influence? Heart Vessels 1990;5(2):102-6.
39. Smith JD, Rose ML, Pomerance A, Burke M, Yacoub MH. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet 1995; 346:1318-22.
40. Opelz G, Wujciak T. The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study. N Engl J Med 1994;330(12):816-9.
41. Smith JD, Danskine AJ, Rose ML, Yacoub MH. Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes. Transplantation 1992; 53:1358-62.
42. Leech SH, Mather PJ, Eisen HJ, Pina IL, Margulies KB, Bove AA, et al. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function. Clin Transplant 1996;10(6 Pt 2):639-45.
43. Yacoub MH, Suitters A, Khaghani A, Rose ML. Localisation of major histocompatability complex antigens in aortic homograft. In: Bodnar E, Yacoub MH, editors. Biologic and bioprosthetic valves. Proceedings of the Thrid International Symposium. New York: Yorke Medical Books; 1986. p. 63-72.
44. Yankah AC, Wottage HU, Muller-Hermelink HK, Feller AC, Lange P, Wessel U, et al. Transplantation of aortic and pulmonary allografts enhanced viability of endothelial cells by cryopreservation, importance of histocompatability. J Card Surg 1987;2(Suppl):209-20.
45. Simon A, Wilhelmi M, Steinhoff G, Harringer W, Brucke P, Haverich A. Cardiac valve endothelial cells: relevance in the long-term function of biologic valve prostheses. J Thorac Cardiovasc Surg 1998;116:609-16.
46. Hoekstra F, Knoop C, Aghai Z, Jutte N, Mochtar B, Bos E, et al. Stimulation of immune-competent cells in vitro by human cardiac valve-derived endothelial cells. Ann Thorac Surg 1995; 60:S131-4.
47. Hoekstra FME, Knoop CJ, Jutte NH, Wassenaar C, Mochtar B, Bos E, et al. Effect of cryopreservation and HLA-DR matching on the cellular immunogenicity of human cardiac valve allografts. J Heart Lung Transplant 1994;13:1095-8.
48. Hoekstra FME, Knoop CJ, Vassen LM, Wassenaar C, Jutte NH, Bos E, et al. Donor-specific immune response against human cardiac valve allograft. J Thorac Cardiovasc Surg 1996;112:281-6.
49. Johnson DL, Rose ML, Yacoub MH. Immunogenicity of human heart valve endothelial cells and fibroblasts. Transplant Proc 1997; 29:984-5.
50. Smith JD, Ogino H, Hunt D, Laylor RM, Rose ML, Yacoub MH. Humoral immune response to human aortic valve homografts. Ann Thorac Surg 1995;60:S127-30.
51. Hoekstra FME, Witvliet M, Knoop CJ, Wassenaar C, Bogers J, Weimar W, et al. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Ann Thorac Surg 1998;66:2022-6.
52. Hogan P, Duplock L, Green M, Smith S, Gall K, Frazer I, et al. Human aortic valve allografts elicit a donor-specific immune response. J Thorac Cardiovasc Surg 1996;112:1260-7.
53. Yacoub MH. In discussion: Yacoub M, Rasmi NR, Sundt TM, Lund O, Boyland E, Radley-Smith R, et al. Fourteen year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:194.
54. Ross D. In discussion: Clarke DR, Campbell DN, Hayward AR, Bishop DA. Degeneration or aortic valve allografts in young recipients. J Thorac Cardiovasc Surg 1993;105:941.
55. Smith JD, Hornick PI, Rasmi N, Rose ML, Yacoub MH. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance. Ann Thorac Surg 1998;66: S212-5.
56. Dignan R, O'Brien M, Passage J, Stephens F, Thornton A, Harrocks S. Influence of HLA matching and associated factors on aortic valve homograft function. J Heart Valve Dis 2000; 9(4):504-11.
57. Jaffe EA. Endothelial cells and the biology of factor VIII. N Engl J Med 1977;196:377.
58. Kadner A, Chen RH, Mitchell RN, Adams DH. Homograft crossmatching is unnecessary due to absence of blood group antigens. Ann Thorac Surg 2001;71:S349-52.
59. Fischlein T, Schutz A, Haushofer M, Frey R, Uhlig A, Detter C, et al. Immunologic reaction and viability of cryopreserved homografts. Ann Thorac Surg 1995;60:S122-6.
60. Moreno-Cabral CE, Miller DC, Shumway NE. A simple technique for aortic valve replacement using freehand allografts. J Card Surg 1988;3:69-76.
61. Barratt-Boyes BG. Aortic allograft valve implantation: freehand or root replacement?. J Card Surg 1994; 9(Suppl):196-7.
62. Willems TP, Takkenberg JJ, Steyerberg EW, Kleyburg-Linkers VE, Roelandt JR, Bos E. Human tissue valves in aortic position: determinants of reoperation and valve regurgitation. Circulation 2001;103:1515-21.
63. Jones EL. Freehand homograft aortic valve replacement: the learning curve: a technical analysis of the first 31 patients. Ann Thorac Surg 1989;48:26-32.
64. Willems TP, van Herwerden LA, Steyerberg EW, Taams MA, Kleyburg VE, Hokken RB, et al. Subcoronary implantation or aortic root replacement for human tissue valves: sufficient data to prefer either technique?. Ann Thorac Surg 1995;60(2 Suppl):S83-6.
65. Knott-Craig CJ, Elkins RC, Stelzer PL, Randolph JD, McCue C, Wright PA, et al. Homograft replacement of the aortic valve and root as a functional unit. Ann Thorac Surg 1995;59:1397-404.
66. Rubay JE, Raphael D, Sluysmans T, Vanoverschelde JLJ, Robert A, Schoevaerdts JC, et al. Aortic valve replacement with allograft/autograft:subcoronary versus intraluminal cylinder or root. Ann Thorac Surg 1995;60:578-82.
67. Jones EL, Shah VB, Shanewise JS, Martin TD, Martin RP, Coto JA, et al. Should the freehand allograft be abandoned as a reliable alternative for aortic valve replacement? Ann Thorac Surg 1995; 59:1397-404.
68. Takkenberg JJ, Herwerden LA, Eijkemans MJ, Bekkers JA, Bogers AJ. Evolution of allograft aortic valve replacement over 13 years: results of 275 procedures. Eur J Cardiothorac Surg 2002; 21:683-91.
69. Doty JR, Salazar JD, Liddicoat JR, Flores JH, Doty DB. Aortic valve replacement with cryopreserved aortic allograft: ten year experience. J Thorac Cardiovascular Surg 1998;115:371-80.
70. O'Brien MF, McGriffin DC, Stafford EG. Allograft aortic valve implantation: techniques for all types of aortic valve and root pathology. Ann Thorac Surg 1989;48:600-9.
71. Rubay JE, Raphael D, Sluysmans T, Vanoverschelde JLJ, Robert A, Schoevaerdts JC, et al. Aortic valve replacement with allograft/autograft:subcoronary versus intraluminal cylinder or root. Ann Thorac Surg 1995;60:578-82.
72. Palka P, Harrocks S, Lange A, Burstow DJ, O'Brien MF. Primary aortic valve replacement with cryopreserved aortic allograft: an echocardiographic follow-up study of 570 patients. Circulation 2002;105:61-6.
73. Barrett-Boyes BG. A method for preparing and inserting a homograft aortic valve. Br J Surg 1965;52:847-56.
74. Mitchell RS, Miller DC, Stinson EB, Oyer PE, Jamieson SW, Baldwin JC, et al. Significant patient-related determinants of prosthetic valve performance. J Thorac Cardiovasc Surg 1986;91:807-17.
75. Langley SM, Livesey SA, Tsang VT, Barron DJ, Lamb RK, Ross JK, et al. Long-term results of valve replacement using antibiotic-sterilised homografts in the aortic position. Eur J Cardiothorac Surg 1996;10:1097-106.
76. Edmunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112(3):708-11.
77. O'Brien MF, Stafford EG, Gardner MAH, Pohlner PG, Tesar PJ, Cochrane AD, et al. Allograft aortic valve replacement: long-term followup. Ann Thorac Surg 1995;60:S65-70.
78. O'Brien MF, McGriffin DC, Stafford EG, Gardner MAH, Pohlner PF, MacLachlan GJ, et al. Allograft aortic valve replacement: long-term comparative clinical analysis of the viable cryopreserved and antibiotic 4°C stored valves. J Card Surg 1991;6(4 Suppl):534-43.
79. Fann JI, Miller DC, Moore KA, Mitchell RS, Oyer PE, Stinson EB, et al. Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg 1996;62(5):1301-11.
80. Frater RW, Furlong P, Cosgrove DM, Okies JE, Colburn LQ, Katz AS, et al. Long-term durability and patient functional status of the Carpentier-Edwards Perimount pericardial bioprosthesis in the aortic position. J Heart Valve Dis 1998;7(1):48-53.
81. Clarke DR, Campbell DN, Hayward AR, Bishop DA. Degeneration of aortic valve allografts in young recipients. J Thorac Cardiovasc Surg 1993;105:934-42.
82. Ross DN. Evolution of the homograft valve. Ann Thorac Surg 1995;59:565-7.
83. Elkins RC. Pulmonary autograft - the optimal substitute for the aortic valve?. N Engl J Med 1994;30:59.
84. Albertucci M, Wong K, Petrou M, Mitchell A, Somerville J, Theodoropoulos S, et al. The use of unstented homograft valves for aortic valve reoperations: review of a twenty-three year experience. J Thorac Cardiovasc Surg 1994;107:152-61.
85. Kirklin JK, Smith D, Novick W, Naftel DC, Kirklin JW, Pacifico AD, et al. Long-term function of cryopreserved aortic homografts: a ten-year study. J Thorac Cardiovasc Surg 1993; 106:154-66.
86. Langley SM, McGuirk SP, Chaudhry MA, Livesey SA, Ross JK, Monro JL. Twenty year follow-up of aortic valve replacement with antibiotic sterilized homografts in two hundred patients. Semin Thorac Cardiovasc Surg 1999;11(4 (Suppl 1)):28-34.
87. Penta A, Qureshi S, Radley-Smith R, Yacoub MH. Patient status 10 or more years after 'fresh' homograft replacement of the aortic valve. Circulation 1984;70(3 Pt 2):I182-6.